ONKI3 | Medical Subject Headings

The ONKI is provided as a part of the ONKI Living Lab - an open lab for testing the latest semantic web technologies in practice, with real users like you. Currently, over 10 000 people are using ONKI each month.

We hope you like the ONKI service and enjoy using it for your purposes!

If you encounter any problems or have improvement ideas, please contact the ONKI team. We are also very much interested in your success stories in using ONKI - please share your experiences!

The ONKI Team

Jouni Tuominen, Living Lab contact person, APIs, widgets, publishing of ontologies, etc.
Eero Hyvönen, professor, head of research group

Former members: Kim Viljanen, Rami Alatalo.

Building the future of the Semantic Web and beyond.

SeCo's homepage
For the latest semantic news, follow us on Twitter and fan us on Facebook!

How can we help you?

Live presentations about ONKI: what it is? how to use it?
Support for creating and publishing ontologies.
Online technical support for using ONKI.
Co-operation in projects.
And more, please ask.

suomeksi på svenska in English

The way property values are displayed: value/row values side by side

The way concept relations are shown: separately in hierarchy

Anti-Obesity Agents

Loading results...


Hierarchy:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Therapeutic Uses ∟ Central Nervous System Agents ∟ Anti-Obesity Agents 17 coordinate concepts 1 subordinate concept ∟ Appetite Depressants ∟ Adjuvants, Anesthesia \| ∟ Alcohol Deterrents \| ∟ Analgesics \| ∟ Anti-Dyskinesia Agents \| ∟ Anticonvulsants \| ∟ Antiemetics \| ∟ Antitussive Agents \| ∟ Central Nervous System Depressants \| ∟ Central Nervous System Stimulants \| ∟ Emetics \| ∟ Hallucinogens \| ∟ Hypnotics and Sedatives \| ∟ Muscle Relaxants, Central \| ∟ Narcotic Antagonists \| ∟ Neuroprotective Agents \| ∟ Nootropic Agents \| ∟ Psychotropic Drugs X
Broader terms:	Medical Subject Headings (MeSH) ∟ Chemical Actions and Uses ∟ Pharmacologic Actions ∟ Therapeutic Uses ∟ Central Nervous System Agents ∟ Anti-Obesity Agents Central Nervous System Agents > Therapeutic Uses > Pharmacologic Actions > Chemical Actions and Uses > Medical Subject Headings (MeSH) X
Narrower terms:	Appetite Depressants X
Annotation:	consider also OBESITY /drug ther X
History note:	Appetite Depressants (1982-1996) \| Obesity (1992-1996) \| Obesity/drug therapy (1992-1996)X
historyNote*:	97 X
publicMeSHNote*:	97 X
Scope note:	Agents that increase energy expenditure and weight loss by neural and chemical regulation. Beta-adrenergic agents and serotoninergic drugs have been experimentally used in patients with non-insulin dependent diabetes mellitus (NIDDM) to treat obesity. X
activeMeSHYear*:	2006 \| 2007X
dateCreated*:	1996-06-13X
dateEstablished*:	1997-01-01X
dateRevised*:	2005-06-30X
recordAuthorizer*:	sjnX
recordMaintainer*:	ssbX
recordOriginator*:	ADPX
Type:	Concept X
Coordinate terms:	Adjuvants, Anesthesia \| Alcohol Deterrents \| Analgesics \| Anti-Dyskinesia Agents \| Anticonvulsants \| Antiemetics \| Antitussive Agents \| Central Nervous System Depressants \| Central Nervous System Stimulants \| Emetics \| Hallucinogens \| Hypnotics and Sedatives \| Muscle Relaxants, Central \| Narcotic Antagonists \| Neuroprotective Agents \| Nootropic Agents \| Psychotropic Drugs X
URI:	X
Labels and equivalent concepts:	Laihdutuslääkkeet (fi) Laihduttamislääkkeet (fi, replaced) Laihdutuslääke (fi, replaced) Laihdutuslääkitys (fi, replaced) Laihduttamislääkitys (fi, replaced) Laihduttamislääke (fi, replaced) Fetma, medel mot (sv) Övervikt, medel mot (sv, replaced) Antiobesity Agents (en, replaced) Antiobesity Drugs (en, replaced) Weight-Loss Drugs (en, replaced) Anti-Obesity Drugs (en, replaced) X
Share:	X